U.S. Markets closed

Is It Time To Buy AbbVie Stock — Or Will Pfizer's Bad News Continue To Hurt?

ALLISON GATLIN
·5 min read
Is It Time To Buy AbbVie Stock — Or Will Pfizer's Bad News Continue To Hurt?
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

AbbVie stock tumbled in mid-March after the Food and Drug Administration requested additional information before considering new approvals for its potential blockbuster drug, Rinvoq.